MaxCyte's Unattributed VC - II Round

MaxCyte raised a round of funding on November 17, 2006.

MaxCyte is a clinical stage biotechnology company aiming to improve therapeutic gene transfer, identifying more targeted ways to deliver drugs, and accelerating the drug discovery process by using new…

Articles about MaxCyte's Unattributed VC - II Round: